Background
Skin aging involves a variety of structural and functional changes, under the influence of various factors. Preaging skin is a relatively new concept describing self‐perceived signs of skin aging that appear in the early 20s–30s and may be triggered by psychological stress. However, it is unclear how young women and healthcare professionals (HCP) understand the association between stress and skin aging.
Aims
We sought to explore the perceptions of stress‐related skin aging among young women and HCPs.
Methods
We performed online surveys of 403 young women (18–34 years), 60 dermatologists, and 60 psychologists residing in major cities in China and Japan. Questions covered skin signs, understanding/perceptions of stress–aging connection, and demographics. Young women also completed DASS‐21 to assess their stress level, which was dichotomized as normal or mild–extremely severe.
Results
The stress level was normal in 52.6% or mild–extremely severe in 47.4% of young women. Greater proportions of women in the mild–extremely severe stress group reported skin manifestations associated with preaging, the top three being “rough skin” (39.3% vs. 24.1%), “slow metabolic rate” (28.8% vs. 14.2%), and “dull skin” (43.5% vs. 29.2%). The top three skin manifestations showing the strongest perceived associations with stress were: “dark eye circles,” “slow metabolic rate,” and “dull skin” (among young women); “acne,” “dry skin,” and “skin rash” (among HCPs).
Conclusions
Young women frequently report high levels of psychological stress and signs of skin aging. Perceptions of stress–skin aging association differ between young women and HCPs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.